[Treatment of bone involvement in Gaucher diseases with imiglucerase combined with miglustat].
Marie
Isabelle
I
Département de Médecine Interne, CHU de Rouen - Bois-Guillaume, 76031 Rouen cedex, France. isabelle.marie@chu-rouen.fr
D017485:1-Deoxynojirimycin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000328:Adult; D001847:Bone Diseases / Q000188:drug therapy* / Q000209:etiology*; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D005260:Female; D005776:Gaucher Disease / Q000150:complications*; D005962:Glucosylceramidase / Q000008:administration & dosage*; D006801:Humans
D004791:Enzyme Inhibitors; D017485:1-Deoxynojirimycin; C059896:miglustat; D005962:Glucosylceramidase; C090568:imiglucerase
Traitement de l'atteinte osseuse au cours d'une maladie de Gaucher par l'association imiglucérase et miglustat.